As of 2025-10-23, the Intrinsic Value of ALX Oncology Holdings Inc (ALXO) is -12.98 USD. This ALXO valuation is based on the model Peter Lynch Fair Value. With the current market price of 1.61 USD, the upside of ALX Oncology Holdings Inc is -906.27%.
Based on its market price of 1.61 USD and our intrinsic valuation, ALX Oncology Holdings Inc (ALXO) is overvalued by 906.27%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -12.98 - -12.98 | -12.98 | -906.27% |
| DDM - Stable | (19.81) - (82.36) | (51.09) | -3273.2% |
| DDM - Multi | (21.18) - (70.04) | (32.71) | -2131.7% |
| Market Cap (mil) | 86.22 |
| Beta | 1.25 |
| Outstanding shares (mil) | 53.55 |
| Enterprise Value (mil) | 86.22 |
| Market risk premium | 4.60% |
| Cost of Equity | 9.03% |
| Cost of Debt | 5.00% |
| WACC | 8.51% |